David Jackson
Principal investigator, leads Adaptive Computing Enterprises, Inc. and Neuraptive Therapeutics, Inc..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$6.1MFederal grants as PI9 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $6.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 17, 2025 | NIH | SBIR Phase II A Novel Anti-inflammatoryand Anti-oxidant Therapy for Treating Non-healing Diabetic Foot Ulcers | $1.0M | CERIA THERAPEUTICS INC |
| Aug 30, 2024 | NIH | SBIR Phase II Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a | $1.2M | CERIA THERAPEUTICS INC |
| Jan 15, 2024 | NIH | SBIR Phase II A Novel Anti-inflammatoryand Anti-oxidant Therapy for Treating Non-healing Diabetic Foot Ulcers | $1.0M | CERIA THERAPEUTICS INC |
| Sep 15, 2023 | NIH | SBIR Phase II Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a | $807K | CERIA THERAPEUTICS INC |
| Sep 15, 2023 | NIH | SBIR Phase II Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a | $807K | CERIA THERAPEUTICS INC |
| Sep 17, 2022 | NIH | SBIR Phase I A Novel Anti-inflammatory and Anti-oxidant Therapy for Treating Non-healing Diabetic Foot Ulcers | $299K | CERIA THERAPEUTICS INC |
| Sep 16, 2022 | NIH | SBIR Phase I A Novel Anti-inflammatory and Anti-oxidant Therapy for Treating Non-healing Diabetic Foot Ulcers | $299K | CERIA THERAPEUTICS INC |
| Apr 1, 2022 | NIH | SBIR Phase I Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a | $299K | CERIA THERAPEUTICS INC |
| Mar 21, 2022 | NIH | SBIR Phase I Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a | $299K | CERIA THERAPEUTICS INC |
Peer ranks
Federal funding#182
Awards as PI#151
Patents#273
Companies
- Adaptive Computing Enterprises, Inc.Leads (SEC Form D) · Software
- Neuraptive Therapeutics, Inc.Leads (SEC Form D) · Medtech
- CERIA THERAPEUTICS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.